1.
Silverberg J, Bieber T, Paller A, Beck L, Kamata M, Puig L, Wiseman M, Ezzedine K, Foley P, Johansson E, Dossenbach M, Akmaz B, Casillas M, Karlsson A, Chovatiya R. Efficacy Comparison of Targeted Systemic Monotherapies Including Lebrikizumab for Moderate-to-Severe Atopic Dermatitis: a Network Meta-Analysis. J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s313. Available from: https://jofskin.org/33014/index.php/skin/article/view/2391